Prioritizing the Patient Voice at Every Stage with Inclusive, Empathetic Communications

Session details:

The availability of clinical trials can present patients and families with a sense of urgency and many questions, so it's critical to execute a communications strategy that's directly informed by the needs of the patient community. This action-oriented case study presentation will explore specific patient engagement strategies that will enable your biotech to communicate with transparency, inclusivity and impact – from tactics to solicit direct patient and family feedback to developing multilingual trial materials and accessible MOA videos. Believing that patient-centric, multi-channel communications needn't be reserved for large pharma,

Karla MacDonald, Chief Corporate Affairs Officer at Entrada Therapeutics, will outline how an impactful communications strategy can be executed on a limited budget – because our communities deserve clarity, empathy and inclusivity at every stage.